+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Communicable Disease Control"

From
From
Chagas Disease: American trypanosomiasis Market - Product Thumbnail Image

Chagas Disease: American trypanosomiasis Market

  • Report
  • January 2024
  • 25 Pages
  • United States
From
Infectious Disease Diagnostics Market Report 2022-2032 - Product Thumbnail Image

Infectious Disease Diagnostics Market Report 2022-2032

  • Report
  • December 2022
  • 325 Pages
  • Global
From
From
U.S. Monkeypox Testing Market - Industry Outlook & Forecast 2023-2025 - Product Thumbnail Image

U.S. Monkeypox Testing Market - Industry Outlook & Forecast 2023-2025

  • Report
  • March 2023
  • 165 Pages
  • United States
From
From
From
From
From
From
From
Mitigating the Next Coronavirus - Product Thumbnail Image

Mitigating the Next Coronavirus

  • Report
  • June 2020
  • 31 Pages
  • Global
Loading Indicator

The Communicable Disease Control market is a subset of the Infectious Disease Testing market, focusing on the prevention, diagnosis, and treatment of communicable diseases. This market includes products and services such as diagnostic tests, vaccines, and therapeutics. Diagnostic tests are used to detect the presence of a communicable disease, while vaccines are used to prevent the spread of communicable diseases. Therapeutics are used to treat communicable diseases. The Communicable Disease Control market is driven by the increasing prevalence of communicable diseases, the growing demand for rapid and accurate diagnosis, and the increasing availability of vaccines. Additionally, the increasing focus on public health initiatives and the development of new technologies are expected to drive the market. Some companies in the Communicable Disease Control market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. Show Less Read more